Validated Reverse Phase HPLC Method for the Determination of DEHP Content in Reconstituting Diluents and in Reconstituted Solutions of Imipenem and Cilastatin for Injection
A simple, rapid, accurate and economic reverse phase HPLC method was developed and validated for determination of di-(2-ethylhexyl)phthalate (DEHP) in reconstituting diluents and reconstituted solutions of imipenem and cilastatin for injection The method was applied to detect any leaching enhancemen...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | E-Journal of Chemistry |
| Online Access: | http://dx.doi.org/10.1155/2010/805248 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850174325647212544 |
|---|---|
| author | A. K. Chaudhary S. Ankushrao Waske S. Yadav T. G. Chandrashekhar Vandana Singh |
| author_facet | A. K. Chaudhary S. Ankushrao Waske S. Yadav T. G. Chandrashekhar Vandana Singh |
| author_sort | A. K. Chaudhary |
| collection | DOAJ |
| description | A simple, rapid, accurate and economic reverse phase HPLC method was developed and validated for determination of di-(2-ethylhexyl)phthalate (DEHP) in reconstituting diluents and reconstituted solutions of imipenem and cilastatin for injection The method was applied to detect any leaching enhancement in presence of imipenem and cilastatin in reconstituted injections. Imipenem and cilastatin for injection is a widely used broad spectrum beta-lactam antibiotic. As per requirements of various regulatory authorities of different countries, DEHP content needs to be monitored in the reconstituting diluents used to reconstitute injections. The proposed method is a unique method wherein DEHP can be determined directly without any sample pre-treatment before analysis. The method can be used as a good quality control tool to control the leaching of DEHP in the reconstituting diluents and reconstituted injections. The method utilizes C18 column (250 × 4.6 mm, 5μ) and a mixture of methanol, propan-2-ol and water as mobile phase. DEHP was detected at 225 nm. The method has low limit of quantification (0.058 μg mL-1) which is much below the acceptance limit calculated as per USFDA tolerance criteria (3.5 μg mL-1 for adults and 0.3 μg mL-1 for neonates and infants). |
| format | Article |
| id | doaj-art-d66357fbd447444e8a9802ba1e9c90b1 |
| institution | OA Journals |
| issn | 0973-4945 2090-9810 |
| language | English |
| publishDate | 2010-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | E-Journal of Chemistry |
| spelling | doaj-art-d66357fbd447444e8a9802ba1e9c90b12025-08-20T02:19:40ZengWileyE-Journal of Chemistry0973-49452090-98102010-01-017250151310.1155/2010/805248Validated Reverse Phase HPLC Method for the Determination of DEHP Content in Reconstituting Diluents and in Reconstituted Solutions of Imipenem and Cilastatin for InjectionA. K. Chaudhary0S. Ankushrao Waske1S. Yadav2T. G. Chandrashekhar3Vandana Singh4Analytical Department, Ranbaxy Research Laboratories, Plot No 20, Sector 18, Udyog Vihar, Gurgaon, Haryana-122001, IndiaAnalytical Department, Ranbaxy Research Laboratories, Plot No 20, Sector 18, Udyog Vihar, Gurgaon, Haryana-122001, IndiaAnalytical Department, Ranbaxy Research Laboratories, Plot No 20, Sector 18, Udyog Vihar, Gurgaon, Haryana-122001, IndiaAnalytical Department, Ranbaxy Research Laboratories, Plot No 20, Sector 18, Udyog Vihar, Gurgaon, Haryana-122001, IndiaAnalytical Department, Ranbaxy Research Laboratories, Plot No 20, Sector 18, Udyog Vihar, Gurgaon, Haryana-122001, IndiaA simple, rapid, accurate and economic reverse phase HPLC method was developed and validated for determination of di-(2-ethylhexyl)phthalate (DEHP) in reconstituting diluents and reconstituted solutions of imipenem and cilastatin for injection The method was applied to detect any leaching enhancement in presence of imipenem and cilastatin in reconstituted injections. Imipenem and cilastatin for injection is a widely used broad spectrum beta-lactam antibiotic. As per requirements of various regulatory authorities of different countries, DEHP content needs to be monitored in the reconstituting diluents used to reconstitute injections. The proposed method is a unique method wherein DEHP can be determined directly without any sample pre-treatment before analysis. The method can be used as a good quality control tool to control the leaching of DEHP in the reconstituting diluents and reconstituted injections. The method utilizes C18 column (250 × 4.6 mm, 5μ) and a mixture of methanol, propan-2-ol and water as mobile phase. DEHP was detected at 225 nm. The method has low limit of quantification (0.058 μg mL-1) which is much below the acceptance limit calculated as per USFDA tolerance criteria (3.5 μg mL-1 for adults and 0.3 μg mL-1 for neonates and infants).http://dx.doi.org/10.1155/2010/805248 |
| spellingShingle | A. K. Chaudhary S. Ankushrao Waske S. Yadav T. G. Chandrashekhar Vandana Singh Validated Reverse Phase HPLC Method for the Determination of DEHP Content in Reconstituting Diluents and in Reconstituted Solutions of Imipenem and Cilastatin for Injection E-Journal of Chemistry |
| title | Validated Reverse Phase HPLC Method for the Determination of DEHP Content in Reconstituting Diluents and in Reconstituted Solutions of Imipenem and Cilastatin for Injection |
| title_full | Validated Reverse Phase HPLC Method for the Determination of DEHP Content in Reconstituting Diluents and in Reconstituted Solutions of Imipenem and Cilastatin for Injection |
| title_fullStr | Validated Reverse Phase HPLC Method for the Determination of DEHP Content in Reconstituting Diluents and in Reconstituted Solutions of Imipenem and Cilastatin for Injection |
| title_full_unstemmed | Validated Reverse Phase HPLC Method for the Determination of DEHP Content in Reconstituting Diluents and in Reconstituted Solutions of Imipenem and Cilastatin for Injection |
| title_short | Validated Reverse Phase HPLC Method for the Determination of DEHP Content in Reconstituting Diluents and in Reconstituted Solutions of Imipenem and Cilastatin for Injection |
| title_sort | validated reverse phase hplc method for the determination of dehp content in reconstituting diluents and in reconstituted solutions of imipenem and cilastatin for injection |
| url | http://dx.doi.org/10.1155/2010/805248 |
| work_keys_str_mv | AT akchaudhary validatedreversephasehplcmethodforthedeterminationofdehpcontentinreconstitutingdiluentsandinreconstitutedsolutionsofimipenemandcilastatinforinjection AT sankushraowaske validatedreversephasehplcmethodforthedeterminationofdehpcontentinreconstitutingdiluentsandinreconstitutedsolutionsofimipenemandcilastatinforinjection AT syadav validatedreversephasehplcmethodforthedeterminationofdehpcontentinreconstitutingdiluentsandinreconstitutedsolutionsofimipenemandcilastatinforinjection AT tgchandrashekhar validatedreversephasehplcmethodforthedeterminationofdehpcontentinreconstitutingdiluentsandinreconstitutedsolutionsofimipenemandcilastatinforinjection AT vandanasingh validatedreversephasehplcmethodforthedeterminationofdehpcontentinreconstitutingdiluentsandinreconstitutedsolutionsofimipenemandcilastatinforinjection |